<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7497732\results\search\drug\results.xml">
  <result pre="conditions determining short life expectancy. Antivirals; low molecular weight heparin;" exact="hydroxychloroquine" post="Â± azithromycin; immunomodulatory agents; high-dose corticosteroids were collected and"/>
  <result pre="Platelets,10^3/Î¼L, median (IQR) 214 (167â€&quot;267) 192 (145â€&quot;261) 204 (159â€&quot;266) 0.007" exact="Creatine" post="phosphokinase, U/L, median (IQR) 82 (52â€&quot;154) 140 (66â€&quot;350) 94"/>
  <result pre="darunavir/c or remdesivir 89 (24.2) 45 (26.2) 134 (24.8) 0.632" exact="Hydroxychloroquine" post="Â± azithromycin 306 (83.8) 121 (69.5) 427 (79.2) &amp;lt;0.001"/>
  <result pre="remdesivir 89 (24.2) 45 (26.2) 134 (24.8) 0.632 Hydroxychloroquine Â±" exact="azithromycin" post="306 (83.8) 121 (69.5) 427 (79.2) &amp;lt;0.001 Heparin prophylaxis"/>
  <result pre="(%) 0.001 No drugs 29 (8.0) 22 (12.6) 51 (9.5)" exact="Hydroxychloroquine" post="+ heparin (Â±lopinavir/r or darunavir/c or azithromycin) 214 (58.6)"/>
  <result pre="or darunavir/c or azithromycin) 214 (58.6) 87 (50.0) 301 (55.8)" exact="Hydroxychloroquine" post="+ lopinavir/r or darunavir/c 41 (11.2) 11 (6.3) 52"/>
  <result pre="+ lopinavir/r or darunavir/c 41 (11.2) 11 (6.3) 52 (9.6)" exact="Hydroxychloroquine" post="Â± azithromycin 49 (13.4) 23 (13.2) 72 (13.4) Heparin"/>
  <result pre="or darunavir/c 41 (11.2) 11 (6.3) 52 (9.6) Hydroxychloroquine Â±" exact="azithromycin" post="49 (13.4) 23 (13.2) 72 (13.4) Heparin only 11"/>
  <result pre="attack or hemiplegia. During hospitalisation, most of the patients received" exact="hydroxychloroquine" post="Â± azithromycin (427, 79.2%) and low weight heparin at"/>
  <result pre="hemiplegia. During hospitalisation, most of the patients received hydroxychloroquine Â±" exact="azithromycin" post="(427, 79.2%) and low weight heparin at prophylactic doses"/>
  <result pre="More than half of the patients were given combinations including" exact="hydroxychloroquine" post="+ heparin Â± lopinavir/r or darunavir/c or azithromycin (301,"/>
  <result pre="combinations including hydroxychloroquine + heparin Â± lopinavir/r or darunavir/c or" exact="azithromycin" post="(301, 55.8%). A total of 117 patients (21.9%) required"/>
  <result pre="&amp;lt;0.001 Thearapy combinations Â No drugs 1.00 1.00 1.00 Â" exact="Hydroxychloroquine" post="+ heparin (Â±lopinavir/r or darunavir/c or azithromycin) 0.33 0.20"/>
  <result pre="&amp;lt;0.001 0.30 0.17 0.50 &amp;lt;0.001 0.28 0.16 0.47 &amp;lt;0.001 Â" exact="Hydroxychloroquine" post="+ lopinavir/r or darunavir/c 0.45 0.22 0.92 0.029 0.42"/>
  <result pre="0.029 0.42 0.20 0.91 0.028 0.42 0.20 0.90 0.025 Â" exact="Hydroxychloroquine" post="or Hydroxychloroquine + azithromycin 0.55 0.31 1.00 0.048 0.57"/>
  <result pre="0.20 0.91 0.028 0.42 0.20 0.90 0.025 Â Hydroxychloroquine or" exact="Hydroxychloroquine" post="+ azithromycin 0.55 0.31 1.00 0.048 0.57 0.30 1.07"/>
  <result pre="0.028 0.42 0.20 0.90 0.025 Â Hydroxychloroquine or Hydroxychloroquine +" exact="azithromycin" post="0.55 0.31 1.00 0.048 0.57 0.30 1.07 0.080 0.53"/>
  <result pre="treatment received. Most of the patients were receiving combinations containing" exact="hydroxychloroquine" post="Â± azithromycin Â± antivirals. The possible effectiveness and toxicity"/>
  <result pre="Most of the patients were receiving combinations containing hydroxychloroquine Â±" exact="azithromycin" post="Â± antivirals. The possible effectiveness and toxicity of hydroxychloroquine"/>
  <result pre="Â± azithromycin Â± antivirals. The possible effectiveness and toxicity of" exact="hydroxychloroquine" post="in Covid-19 disease is debated: laboratory studies showed antiviral"/>
  <result pre="prospective cohort studyLancet39520201763177132442528 DevauxC.A.RolainJ.M.ColsonP.RaoultD.New insights on the antviral effects of" exact="chloroquine" post="against coronavirus: what to expect for COVID-19?Int J Antimicrob"/>
  <result pre="for COVID-19?Int J Antimicrob Agents555202010593810.1016/j.antimicag.2020.105938[Published online 12 March]32171740 GautretF.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
  <result pre="is effective in inhibiting SARS-CoV-2 infection in vitroCell Discov620201632194981 MehraM.R.DesaiS.S.RuschitzkaF.PatelA.N.RETRACTED:" exact="hydroxychloroquine" post="or chloroquine with or without a macrolide for treatment"/>
  <result pre="in inhibiting SARS-CoV-2 infection in vitroCell Discov620201632194981 MehraM.R.DesaiS.S.RuschitzkaF.PatelA.N.RETRACTED: hydroxychloroquine or" exact="chloroquine" post="with or without a macrolide for treatment of COVID-19:"/>
 </snippets>
</snippetsTree>
